• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Ophthalmology

Intravitreal bevacizumab injections effective for treating central serous chorioretinopathy

byKathleen LauandAlex Chan
September 16, 2020
in Ophthalmology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Intravitreal bevacizumab injections for central serous chorioretinopathy show long-term outcomes of complete remission in 90% of patients,

2. Thick choroids and serous retinal detachment at baseline were risk factors for recurrence.

Evidence Rating Level: 2 (Good)

Central serous chorioretinopathy (CSC) is an ocular disease characterized by retinal detachment due to the presence of serous fluid. Though acute CSC is often self-limiting, treatment is often recommended to decrease risk of irreversible visual loss. Chronic CSC can also lead to permanent visual defects. Treatment with photodynamic therapy is more superior and consistent than intravitreal anti-VEGF medications but requires specialized equipment and may result in unwanted complications. Intravitreal anti-VEGF medications, including intravitreal bevacizumab injections (IVBI), thus have a role in treatment despite clinical outcomes being more inconsistent. The long-term treatment outcomes of IVBI injections has not been studied. In this retrospective, interventional, single-center study, patient information was extracted from those who underwent IVBI treatment for CSC (which included injections every 4 weeks until complete resolution (CR) was achieved) and had at least a 2-year follow-up (mean follow-up 35 months). Information on a total of 44 patients and 45 eyes was collected, among which 40 eyes were able to achieve complete remission. The primary outcome, to measure treatment response, showed that of the 40 eyes with at least one CR, 20 had developed at least one recurrence with an average duration of 11.6 months ± 6.4 months from CR to first recurrence. As well, the average number of IVBI required to reach first CR did not differ significantly among eyes that had or did not have previous recurrences (2.6 ± 1.6 vs. 2.9 ± 1.9, p=0.658). The secondary outcome, to determine if there are any factors that are related to recurrences, revealed patients with baseline characteristics of thick choroids (subfoveal choroidal thickness > 300um, B=1.980, p=0.019) and serous retinal detachment (B= -2.580, p=0.032) were associated with higher risk of recurrence. This study confirms the potential of IVBI as a potential treatment option for those desiring treatment and avoiding or are unable to access PDT therapy, as 90% of eyes were able to achieve at least one complete remission.

Click to read the study in PlosONE

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Long-term variability in intraocular pressures associated with glaucoma disease progression

Artificial intelligence-aided analysis of retinal imaging may predict cardiovascular mortality

Shorter time to surgical repair of macula-off retinal detachment may improve final visual acuity

Tags: Detached Retinaopthalmologyretina
Previous Post

#VisualAbstract: SSRI use in pediatric patients associated with increased risk of type 2 diabetes

Next Post

SARS-CoV-2 is associated with higher incidence of Kawasaki disease in children

RelatedReports

Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren
Chronic Disease

Long-term variability in intraocular pressures associated with glaucoma disease progression

November 8, 2022
Patient Basics: Retinopathy
Ophthalmology

Artificial intelligence-aided analysis of retinal imaging may predict cardiovascular mortality

October 14, 2022
Patient Basics: Detached Retina
2 Minute Medicine

Shorter time to surgical repair of macula-off retinal detachment may improve final visual acuity

August 8, 2022
Masks for personal protection for SARS-CoV-2 infection
Ophthalmology

Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic

July 5, 2022
Next Post
SARS-CoV-2 is associated with higher incidence of Kawasaki disease in children

SARS-CoV-2 is associated with higher incidence of Kawasaki disease in children

#VisualAbstract: No significant differences in outcomes between pre- and post-treatment administration of P2Y12 inhibitors for NSTE-ACS

#VisualAbstract: No significant differences in outcomes between pre- and post-treatment administration of P2Y12 inhibitors for NSTE-ACS

Psychological impact of COVID-19 on health care workers in Singapore

Association between Aspirin and other NSAIDs with depression, anxiety, and stress-related disorders following a cancer diagnosis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Mycobacterium abscessus infections after cardiac surgery linked to hospital water system
  • The 2 Minute Medicine Podcast Episode 11
  • Wellness Check: Spirituality
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options